AI assistant
Info Edge(India) Ltd. — Capital/Financing Update 2023
Jul 10, 2023
61935_rns_2023-07-10_522a993b-f8a8-4c04-9c17-a4bd52e273ad.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [237 x 77] intentionally omitted <==
Date: July 10, 2023
1. The Manager- Listing National Stock Exchange of India Limited (Scrip Code: NAUKRI)
2. The Manager- Listing BSE Limited (Scrip Code: 532777)
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam ,
This is to inform you that Redstart Labs (India) Ltd. (“Redstart”), a wholly-owned subsidiary of the Company has agreed to invest Rs. 98,94,000/- in Brainsight Technology Private Limited. The details of the transaction are given as under:
==> picture [481 x 385] intentionally omitted <==
----- Start of picture text ----- Sl. Particulars DetailsNo.1. Name of the target entity, details in brief such Brainsight Technology Private Limitedas size, turnover etc. (“Brainsight”)Address: No. 677, 1st Floor, 27th Main, 13th Cross,Sector 1, HSR Layout, Bangalore 560102Details as on March 31, 2023 (in Rs.)Turnover PAT Networth27,59,016.20* -3,28,82,716.43 15,88,234.84*: includes grants2. Whether the acquisition would fall within Brainsight is an existing investee company whereinrelated party transaction(s) and whether the Redstart holds 4% on a fully converted & diluted basis.promoter/promoter group/group companieshave any interest in the entity being acquired? Promoters of the Company have no interest in the saidIf yes, nature of interest and details thereof and investment.whether the same is done at “arm’s length”The transaction is done at Arm’s Length basis.3. Industry to which the entity being acquired Brainsight is engaged in the business of healthcarebelongs technology, where it uses AI enabled application toprovide evidence-based treatment hooks forneurosurgeons, psychiatrists and neurologists; and aprivate and empathetic digital aid for patients, and relatedbusiness activities.4. Objects and effects of acquisition (including This follow on investment by the Company throughbut not limited to, disclosure of reasons for Redstart is in furtherance of Company’s investmentacquisition of target entity, if its business is strategy, which includes making external financialoutside the main line of business of the listed investments that are focused on value creation in theentity. medium to long term.----- End of picture text -----
==> picture [396 x 53] intentionally omitted <==
==> picture [481 x 547] intentionally omitted <==
----- Start of picture text ----- 5. Brief details of any governmental or regulatory Not Applicableapprovals required for the acquisition.6. Whether any governmental or regulatory Not Applicableapprovals required for the acquisition7. Provide brief details of the governmental or Not Applicableregulatory approvals required for theacquisition8. Indicative time period for completion of Immediateacquisition9. Nature of Consideration- whether cash Cash Considerationconsideration or share swap and details of thesame.10. Cost of acquisition or the price at which the Rs. 98,94,000/-.shares are acquired.11. Percentage of shareholding/control acquired Redstart has agreed to invest an aggregate amount of Rs.and/ or number of shares acquired. 98,94,000/- (Rupees Ninety-eight lakh ninety-fourthousand Only) by way of subscribing to ConvertibleNotes. Since the Note would be converted into shares inthe next round basis the valuation at that time, aggregateshareholding of the Company through Redstart, post thisinvestment cannot be estimated at the time of making theintimation.12. Brief background about the entity acquired in Brief Background : Brainsight is engaged in the businessterms of products/line of business acquired, of healthcare technology, where it uses AI enableddate of incorporation, history of last 3 years application to provide evidence-based treatment hooks forturnover, country in which the acquired entity neurosurgeons, psychiatrists and neurologists; and ahas presence and any other significant private and empathetic digital aid for patients, and relatedinformation (in brief). business activities.Date of Incorporation : May 31, 2019Country in which the acquired entity has presence :IndiaLast three years turnover*: (Rs.)2022-23 2021-2022 2020-202127,59,016.20 21,42,087.00 31,90,000.00*: Includes grants----- End of picture text -----
This is for your information and records.
Thanking You.
Yours faithfully, For Info Edge (India) Ltd.
CHINTAN Digitally signed by CHINTAN ARVIND ARVIND THAKKAR Date: 2023.07.10 THAKKAR 11:38:41 +05'30' Chintan Thakkar Whole-time Director & CFO
==> picture [396 x 53] intentionally omitted <==